TABLE 1.
Demographic, neuropsychological, behavioral, and clinical summary
| Control‐NU (20) | Control‐CU (21) | PWH‐NU (22) | PWH‐CU (18) | p value | |
|---|---|---|---|---|---|
| Demographics | |||||
| Age (years) a | 43.05 (10.38) | 37.33 (9.86) | 38.68 (10.30) | 43.33 (12.91) | n.s. |
| Education (years) a | 15.85 (1.30) | 14.87 (1.89) | 14.95 (2.08) | 13.77 (1.95) | <.05* |
| Sex (F/M) a | 9/11 | 9/12 | 4/18 | 4/14 | n.s. |
| Neuropsychology | |||||
| Fine motor b | −0.02 (1.01) | −0.84 (1.00) | −0.50 (1.04) | −0.96 (1.19) | n.s. |
| Learning and memory b | 0.40 (0.95) | −0.59 (0.81) | −0.39 (0.82) | −0.08 (1.09) | n.s. |
| Language b | −0.15 (0.99) | −0.17 (0.72) | −0.22 (0.78) | −0.29 (0.85) | n.s. |
| Attention b | 0.45 (0.81) | 0.19 (0.94) | 0.13 (0.59) | 0.14 (0.63) | n.s. |
| Executive function b | 0.1 (0.87) | −0.60 (0.90) | −0.37 (1.11) | −0.43 (0.93) | n.s. |
| Visuospatial task | |||||
| Reaction time (ms) b , c | 517.33 (66.00) | 544.69 (58.30) | 568.36 (47.43) | 564.63 (67.26) | <.01** |
| Accuracy b | 97.79 (3.05) | 97.43 (2.86) | 96.07 (3.91) | 96.31 (4.28) | n.s. |
| Substance use | |||||
| Audit‐C b | 2.45 (1.95) | 3.23 (1.81) | 2.40 (1.70) | 2.72 (2.05) | n.s. |
| Cannabis frequency d | – | 33.85 (17.04) | – | 27.72 (20.75) | n.s. |
| HIV markers | |||||
| CD4 nadir d | – | – | 282.63 (173.69) | 323.00 (181.47) | n.s. |
| Current CD4 d | – | – | 906.09 (500.35) | 771.77 (391.86) | n.s. |
| Years diagnosed | – | – | 9.77 (7.22) | 9.28 (6.17) | n.s. |
Note: Neuropsychology scores are functional domain composite z‐scores standardized. *p < .05, **p < .01, n.s. = p > .05.
Abbreviations: CU, cannabis users; NU, nonusers.
a
One‐way ANOVA/Chi‐square.
b
2 × 2 ANOVA.
c
Main effect of HIV.
d
t‐test/Wilcoxon.